HC Wainwright & Co. Reiterates Buy on FocalTherics, Maintains $10 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 89.6%

Neg 0% Neu 89.6% Pos 0%

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates FocalTherics (NASDAQ:FOCL) with a Buy and maintains $10 price target.